HEMOCOVID-19 and VASCOVID

Two international initiatives led by ICFO and Hospital Parc Taulí to better manage COVID-19 patients thanks to an innovative biophotonics tool.

http://hemocovid19-project.org/
http://www.vascovid.eu/

Network project partners and key network researchers involved

Turgut Durduran

Jaume Mesquida

Ricard Ferrer
Marina Garcia Garcia

Pedro Castro

Judith Marin Corral
Purificación Pérez Teran

Project summary

HEMOCOVID-19 and VASCOVID projects aim to introduce and test clinically a portable, non-invasive and real-time health monitoring platform for the stratification of COVID-19 patients according to the urgency of their need for aggressive respiratory therapy and to prognose further unexpected deterioration of their respiratory status.

Phase I: HEMOCOVID-19: At the very beginning of the current SARS-CoV-2 pandemic, ICFO assembled and adapted a set of 10 commercial near-infrared spectroscopy (NIRS) devices and distributed them to clinical partners to carry out a pilot clinical research campaign aiming to characterize the microvascular health in patients entering in the ICU with acute respiratory distress syndrome (ARDS). Currently, HEMOCOVID-10 consortium counts with 11 participating institutions from five countries. More info on: http://hemocovid19-project.org

Phase II: VASCOVID: Based on the HEMOCOVID-19 experience, its sister project VASCOVID aims to develop a mobile biophotonics platform that will address the shortcomings of currently available NIRS methods and to exploit results towards clinical translation in order to suggest personalized management strategies for the evaluation of microvascular health in COVID-19 patients. VASCOVID is supported by the European Commission, is coordinated by ICFO, led by ICREA Prof. at ICFO Turgut Durduran, and it involves six more partners from Spain, Ireland, Italy and the Netherlands. More info on: http://www.vascovid.eu